Microbiologics has formed a new molecular products division with the acquisition of the assets of Phthisis Diagnostics, including their patented process for designing and manufacturing molecular standards. These molecular standards are specifically designed to be used as performance controls for a wide variety of molecular instruments and assays in pharmaceutical, food safety and clinical testing.

Brad Goskowicz, Microbiologics Chief Executive Officers, commented, "These innovative molecular standards will lay the foundation for Microbiologics to design and launch a broad collection of molecular products and custom services. It will expand our range of biomaterials to include viruses and other hard to grow microorganisms." Microbiologics is currently the global leader in producing an array of lyophilized microorganism products in convenient, ready-to-use formats for quality control of microbiological testing.

Joining the Microbiologics senior management team is Brian Beck, PhD, Vice President of Molecular Products and Services. Doctor Beck earned his PhD in Bacteriology from the University of Wisconsin-Madison and has spent the last ten years at ATCC in Manassas, Virginia where he managed the Microbiology Collection. "I'm quite excited to extend what Microbiologics has done with their culture business and bring that same practical, user-friendly type of format to the molecular diagnostic business," Beck said.

To commence their new initiative in molecular sciences, Microbiologics will be exhibiting at the upcoming Association for Molecular Pathology (AMP) 2013 Annual Meeting from November 14-16, 2013 in Phoenix, Arizona. Visit them at booth #231 to learn more.